WHO approves Moderne’s COVID-19 vaccine for emergency use
The WHO has given emergency use approval to Moderne's COVID-19 vaccine [File: Carlos Osorio/Reuters]
Approval comes as cases around the world increase, putting pressure on governments to speed up vaccination programs.
The WHO has given emergency use approval to Moderne’s COVID-19 vaccine [File: Carlos Osorio/Reuters]
The World Health Organization has listed Moderne’s COVID-19 vaccine for emergency use, the agency said Friday, the fifth shot to be given status intended to accelerate countries’ own approval of shots.
“The goal is to make drugs, vaccines and diagnostics available as soon as possible to address the emergency,” the WHO said in a statement.
WHO assistant director general Mariangela Simao said Friday it was important to have more vaccines available due to delivery problems for other injections, including from India, a major source of vaccines for the global COVAX sharing program.
vaccines.India has limited exports due to a home infection crisis that has overwhelmed the country’s health system. Moderne this week announced an expansion plan for its manufacturing network to increase capacity to up to three billion doses by 2022.
WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) had already recommended Moderne’s vaccine for all age groups in January. 18 years and older.
Pfizer and its German partner Bion Tech’s injection, an mRNA vaccine like Moderne’s, was the first vaccine to receive a WHO emergency list in the closing hours of 2020. Since then, the WHO has added vaccines from Astra Zeneca-SK Bio, Serum Institute of India and Johnson & Johnson vaccines to the list.
The UN health agency is still considering COVID-19 vaccines developed by Chinese manufacturers Sinopharm and Sinovac after an extensive review, with decisions due by the end of next week. SOURCE: REUTERS